Aiga Grandane

Aiga Grandane

Auto-generated profile, based on publicly available information

Aiga Grandane

Latvian Institute of Organic Synthesis

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2012 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
KTKaspars Tars
Kaspars Tars
DVDaniela Vullo
Daniela Vullo
AKAndris Kazaks
Andris Kazaks
JLJanis Leitans
Janis Leitans
ALAlons Lends
Alons Lends
Claudiu SupuranClaudiu Supuran
Claudiu Supuran

15 April 2015 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
AGAiga Grandane
Aiga Grandane
MTMuhammet Tanc
Muhammet Tanc
Lorenzo Di Cesare MannelliLorenzo Di Cesare Mannelli
Lorenzo Di Cesare Mannelli
FCFabrizio Carta
Fabrizio Carta
CGcarla ghelardini
carla ghelardini
Claudiu SupuranClaudiu Supuran
Claudiu Supuran

1 March 2014 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
AGAiga Grandane
Aiga Grandane
MTMuhammet Tanc
Muhammet Tanc
RZRavis Zalubovskis
Ravis Zalubovskis
Claudiu SupuranClaudiu Supuran
Claudiu Supuran

1 March 2014 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
AGAiga Grandane
Aiga Grandane
MTMuhammet Tanc
Muhammet Tanc
RZRavis Zalubovskis
Ravis Zalubovskis
Claudiu SupuranClaudiu Supuran
Claudiu Supuran

1 April 2015 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
AGAiga Grandane
Aiga Grandane
MTMuhammet Tanc
Muhammet Tanc
RZRavis Zalubovskis
Ravis Zalubovskis
Claudiu SupuranClaudiu Supuran
Claudiu Supuran

1 January 2020 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Open access
Mikhail KrasavinMikhail Krasavin
Mikhail Krasavin
RŽRaivis Žalubovskis
Raivis Žalubovskis
AGAiga Grandāne
Aiga Grandāne
IDIlona Domračeva
Ilona Domračeva
PZPetr Zhmurov
Petr Zhmurov
Claudiu SupuranClaudiu Supuran
Claudiu Supuran
The hypothesis that sulfocoumarin acting as inhibitors of human carbonic anhydrase (CA, EC 4.2.1.1) cancer-associated isoforms hCA IX and – hCA XII is being able to also inhibit thioredoxin reductase was verified and confirmed. The dual targeting of two cancer cell defence mechanisms, i.e. hypoxia and oxidative stress, may both contribute to the observed antiproliferative profile of these compounds against many cancer cell lines. This unprecedented dual anticancer mechanism may lead to a new approach for designing innovative therapeutic agents. Graphical Abstract